BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36593066)

  • 1. Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
    Dai J; Bai X; Gao X; Tang L; Chen Y; Sun L; Wei X; Li C; Qi Z; Kong Y; Cui C; Chi Z; Sheng X; Xu Z; Lian B; Li S; Yan X; Tang B; Zhou L; Wang X; Xia X; Guo J; Mao L; Si L
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36593066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Epigenetic Profiling Reveals Distinct Features of Mucosal Melanomas Associated with Immune Cell Infiltration and Their Clinical Implications.
    Dai J; Jia J; Zhang F; Liu K; Xi Y; Yuan P; Mao L; Bai X; Wei X; Wang B; Li J; Xu Y; Liu T; Chang S; Shao Y; Guo J; Ying J; Si L
    Cancer Res Commun; 2024 May; ():. PubMed ID: 38695555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
    Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
    Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus.
    Tsuyama S; Kohsaka S; Hayashi T; Suehara Y; Hashimoto T; Kajiyama Y; Tsurumaru M; Ueno T; Mano H; Yao T; Saito T
    Histopathology; 2021 Jan; 78(2):240-251. PubMed ID: 32654197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review.
    Sanlorenzo M; Ribero S; Osella Abate S; Mariani S; Strignano P; Salizzoni M; Savoia P; Fierro MT; Quaglino P
    G Ital Dermatol Venereol; 2020 Oct; 155(5):680-682. PubMed ID: 33295742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiregional Sequencing Reveals Genomic Alterations and Clonal Dynamics in Primary Malignant Melanoma of the Esophagus.
    Li J; Yan S; Liu Z; Zhou Y; Pan Y; Yuan W; Liu M; Tan Q; Tian G; Dong B; Cai H; Wu N; Ke Y
    Cancer Res; 2018 Jan; 78(2):338-347. PubMed ID: 28972077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus.
    Li J; Guan W; Ren W; Liu Z; Wu H; Chen Y; Liu S; Quan X; Yang Z; Jiang C; He J; Xiao X; Ye Q
    Neoplasia; 2022 Aug; 30():100811. PubMed ID: 35661532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
    Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
    Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pathological features of 180 cases with primary esophageal malignant melanoma].
    Meng H; Zhao XK; Song X; Han WL; Zhou SL; Sun L; Hu SJ; Cheng R; Wang M; Yin YH; Li YZ; Ding Y; Wang LD
    Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):949-954. PubMed ID: 34530578
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients.
    Wang X; Kong Y; Chi Z; Sheng X; Cui C; Mao L; Lian B; Tang B; Yan X; Si L; Guo J
    Thorac Cancer; 2019 Apr; 10(4):950-956. PubMed ID: 30864295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and prognosis of primary malignant melanoma of the esophagus.
    Chen H; Fu Q; Sun K
    Medicine (Baltimore); 2020 Jul; 99(28):e20957. PubMed ID: 32664098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Features, Staging Classification, and Clinical Outcomes of Esophageal Melanoma: Evaluation of a Pooled Case Series.
    Sun H; Zhu N; Gong L; Lan L; Yu Z; Pan Z
    Front Oncol; 2022; 12():858145. PubMed ID: 35847861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant melanoma of the esophagus: a case report.
    Li YH; Li X; Zou XP
    World J Gastroenterol; 2014 Mar; 20(10):2731-4. PubMed ID: 24627611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary esophageal malignant melanoma successfully treated with anti-PD-1 antibody for retroperitoneal recurrence after esophagectomy: A case report.
    Endo F; Akiyama Y; Onishi M; Fujisawa R; Sasaki N; Nikai H; Baba S; Sugimoto R; Kimura T; Takahara T; Iwaya T; Otsuka K; Nitta H; Koeda K; Sugai T; Sasaki A
    Int J Surg Case Rep; 2020; 75():152-156. PubMed ID: 32950945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: a single-institute retrospective analysis.
    Harada K; Mine S; Yamada K; Shigaki H; Oya S; Baba H; Watanabe M
    Dis Esophagus; 2016 May; 29(4):314-9. PubMed ID: 25708974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: a single-center experience.
    Wang S; Tachimori Y; Hokamura N; Igaki H; Kishino T; Kushima R
    Ann Thorac Surg; 2013 Sep; 96(3):1002-6. PubMed ID: 23810175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus.
    Sun H; Gong L; Zhao G; Zhan H; Meng B; Yu Z; Pan Z
    J Surg Oncol; 2018 Mar; 117(4):588-596. PubMed ID: 29266237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy.
    Rose AAN; Armstrong SM; Hogg D; Butler MO; Saibil SD; Arteaga DP; Pimentel Muniz T; Kelly D; Ghazarian D; King I; Kamil ZS; Ross K; Spreafico A
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of primary malignant melanoma of the esophagus: clinical features, pathology, management and prognosis.
    Iwanuma Y; Tomita N; Amano T; Isayama F; Tsurumaru M; Hayashi T; Kajiyama Y
    J Gastroenterol; 2012 Jan; 47(1):21-8. PubMed ID: 22048255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.